Issue 2, 2024

Emerging perspectives on 3D printed bioreactors for clinical translation of engineered and bioprinted tissue constructs

Abstract

3D printed/bioprinted tissue constructs are utilized for the regeneration of damaged tissues and as in vitro models. Most of the fabricated 3D constructs fail to undergo functional maturation in conventional in vitro settings. There is a challenge to provide a suitable niche for the fabricated tissue constructs to undergo functional maturation. Bioreactors have emerged as a promising tool to enhance tissue maturation of the engineered constructs by providing physical/biological cues along with a controlled nutrient supply under dynamic in vitro conditions. Bioreactors provide an ambient microenvironment most appropriate for the development of functionally matured tissue constructs by promoting cell proliferation, differentiation, and maturation for transplantation and drug screening applications. Due to the huge cost and limited availability of commercial bioreactors, there is a need to develop strategies to make customized bioreactors. Additive manufacturing (AM) may be a viable tool to fabricate custom designed bioreactors with better efficiency and at low cost. In this review, we have extensively discussed the importance of bioreactors in functionalizing tissue engineered/3D bioprinted scaffolds for bone, cartilage, skeletal muscle, nerve, and vascular tissue. In addition, the importance and fabrication of customized 3D printed bioreactors for the maturation of tissue engineered constructs are discussed in detail. Finally, the current challenges and future perspectives in translating commercial and custom 3D printed bioreactors for clinical applications are outlined.

Graphical abstract: Emerging perspectives on 3D printed bioreactors for clinical translation of engineered and bioprinted tissue constructs

Article information

Article type
Review Article
Submitted
14 Aug 2023
Accepted
09 Nov 2023
First published
17 Nov 2023

J. Mater. Chem. B, 2024,12, 350-381

Emerging perspectives on 3D printed bioreactors for clinical translation of engineered and bioprinted tissue constructs

M. Thangadurai, S. S. Srinivasan, M. P. Sekar, S. Sethuraman and D. Sundaramurthi, J. Mater. Chem. B, 2024, 12, 350 DOI: 10.1039/D3TB01847D

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements